drugset / Trial / NCT00035802

A Study to Evaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I Disorder

NCT00035802

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine the safety and efficacy of topiramate in adolescents with manic or mixed episodes of Bipolar I Disorder.

Timeline

Start
2002-01
Primary completion
Completion
2002-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Topiramate Small molecule 400 mg Oral
Subject Topiramate Small molecule 600 mg Oral